JANUARY 20256Managing EditorAlex D'souzaVisualizerChris LynnPresley MeadowJANUARY - 2025, Volume 07 - Issue 39 (ISSN 2691-4093) Published by ValleyMedia, Inc. Emailsales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comTo subscribe to Medical Tech OutlookVisit www.medicaltechoutlook.com Copyright © 2025 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAlex D'souzaManaging Editoreditor@medicaltechoutlook.comArtificial intelligence is revolutionising colonoscopy by addressing one of its critical limitations--the variability in adenoma detection rates (ADR) among clinicians. Studies indicate that AI-enhanced systems, such as computer-aided detection (CADe) tools, can identify polyps with remarkable accuracy, even those that are small, flat or obscured. For instance, clinical trials have demonstrated that CADe systems can increase ADR by up to 50 percent, significantly reducing the risk of interval cancers. By providing real-time alerts during procedures, AI ensures that no suspicious lesion goes unnoticed, bridging the gap between human expertise and machine precision.The future of colonoscopy may also witness a shift towards non-invasive diagnostic tools as adjuncts or alternatives for specific patient populations. Techniques like liquid biopsy, which detects circulating tumour DNA (ctDNA), and stool-based multi-target DNA testing, such as Cologuard®, are gaining traction. While these tests are not replacements for colonoscopy, they can serve as valuable triage tools to identify high-risk individuals who would benefit most from further endoscopic evaluation.Moreover, innovations in bowel preparation--often cited as a barrier to patient compliance--are making the process more tolerable. Novel low-volume and taste-masked preparations, coupled with personalised hydration protocols, are improving the patient experience and ensuring optimal visualisation during the procedure.Driven by these trends, the Colonoscopy Market is predicted to reach $5.71 billion by 2031 at a 4.94 percent CAGR.In this edition of MedTech Outlook Europe, we provide insights into recent developments in the colonoscopy market and how companies offer services aligned with the latest trends.The magazine features a thought leadership article from Kevin Watson, MD, FAAP, Assistant Director of Clinical Informatics ­ Speciality Systems at Akron Children's Hospital, who highlights the potential of AI in transforming the field of paediatric gastroenterology. It also features an article from Anne Mary K. Montero, Medical Director at Indiana University Health, who sheds light on the increased awareness of mental health issues and the importance of addressing them in the healthcare space.In this edition of MedTech Outlook Europe, we also feature the stories of top MedTech companies delivering solutions that play a crucial role in driving innovation and improving healthcare quality. One of them is Augere Medical, a pioneer in AI-driven polyp detection, aiming to revolutionise colonoscopy screenings and improve patient outcomes.In this edition featuring the Colonoscopy Guidance System of the Year in Europe 2025, we hope you find the right partner to meet your organisation's needs.Let us know your thoughts!A Giant Leap towards Reducing the Global Burden of Colorectal CancerEDITORIALEditorial StaffJoe PhilipLaura PintoJoshua ParkerMerlin WatsonSarah FernandesGina ClumskyYenny TurnerTiffany Hayworth
< Page 5 | Page 7 >